Literature DB >> 10923773

Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology.

H Kappauf1, D Leykauf-Ammon, U Bruntsch, M Horneber, G Kaiser, G Büschel, W M Gallmeier.   

Abstract

A sizeable percentage of patients receiving conventional medical treatment also use unconventional medicine (UM). Surveys indicate that the prevalence of and motivation for the pursuit of the different approaches of UM is subject to individual, geographical, cultural and disease-related factors. We were interested in the concurrent use of and attitudes towards UM in patients who underwent conventional medical treatment in our oncologically orientated department of internal medicine in a regionally dominant teaching hospital. A representative sample (n = 131) of all inpatients and outpatients receiving treatment in the department or in its oncological/haematological outpatient clinic were asked to participate in a cross-sectional interview study on the use of unconventional therapies. In all, 128 patients (97.7%) agreed to participate in the study, and 65% of these patients were suffering from malignancies. Use of unconventional treatment was reported by 24% of all patients for their current medical problem, and 16% of the remaining patients had been thinking of adjunctive use. The use of UM was significantly higher among oncological patients (32%), and among oncological outpatients in particular (50%), than among patients with acute or chronic non-malignant diseases. Female patients predominated among the users of UM (71%). UM mainly took the form of various pharmacological and dietary approaches. Patients availing themselves of UM most frequently identified physicians (41%) as the source of treatment recommendation. Only 18% of the users of UM relied on these methods as a chance of cure. Use of UM was not generally motivated by dissatisfaction with conventional medical care. Only half the users informed their hospital physician of their adjunctive use of UM. Nearly 2 out of 3 of the users contended that UM had contributed to a mild or distinct improvement in their physical or psychological wellbeing. The use of UM in modern health care systems represents a widespread and intricate phenomenon, which cannot be understood by focusing exclusively on the objective assessment of clinical efficacy. Use of UM may be related more to a disease's unfavourable attribution than to its medically expected outcome. Coherence with individual illness paradigms and perceived efficacy are apparently important factors in patients' use of UM. These subjective aspects need to be recognised in caring patient-doctor communication.

Entities:  

Mesh:

Year:  2000        PMID: 10923773     DOI: 10.1007/s005209900111

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

1.  Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients.

Authors:  Kristen Arthur; Juan Carlos Belliard; Steven B Hardin; Kathryn Knecht; Chien-Shing Chen; Susanne Montgomery
Journal:  Integr Cancer Ther       Date:  2012-02-07       Impact factor: 3.279

2.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

Review 3.  Effects of complementary and integrative medicine on cancer survivorship.

Authors:  Moshe Frenkel; Victor Sierpina; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2015       Impact factor: 5.075

4.  Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality.

Authors:  Eran Ben-Arye; Gil Bar-Sela; Moshe Frenkel; Abraham Kuten; Doron Hermoni
Journal:  Support Care Cancer       Date:  2005-08-16       Impact factor: 3.603

5.  Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies.

Authors:  P A Fasching; F Thiel; K Nicolaisen-Murmann; C Rauh; J Engel; M P Lux; M W Beckmann; M R Bani
Journal:  Support Care Cancer       Date:  2007-03-01       Impact factor: 3.603

6.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

7.  [Communication in oncology].

Authors:  H W Kappauf
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

8.  Complementary and alternative medicine in the management of hypertension in an urban Nigerian community.

Authors:  Pauline E Osamor; Bernard E Owumi
Journal:  BMC Complement Altern Med       Date:  2010-07-19       Impact factor: 3.659

Review 9.  Effective communication about the use of complementary and integrative medicine in cancer care.

Authors:  Moshe Frenkel; Lorenzo Cohen
Journal:  J Altern Complement Med       Date:  2013-07-17       Impact factor: 2.579

10.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Authors:  Mary Ann Richardson; Louise C Mâsse; Kelly Nanny; Christina Sanders
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.